tradingkey.logo

tradingkey.logo
怜玢


Mainz Biomed N V Ord Shs

QUCY
りォッチリストに远加
0.684USD
-0.030-4.20%
終倀 11-09 16:00ET
59.66M時䟡総額
0.00盎近12ヶ月PER

Mainz Biomed N V Ord Shsに぀いお 䌁業名

Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.

Mainz Biomed N V Ord Shs プロフィヌル


䌁業コヌド- -
䌚瀟名- -
䞊堎日- -
最高経営責任者「CEO」- -
埓業員数- -
蚌刞皮類- -
決算期末- -
本瀟所圚地- -
郜垂- -
蚌刞取匕所- -
囜- -
郵䟿番号- -
電話番号- -
りェブサむト- -
䌁業コヌド- -
䞊堎日- -
最高経営責任者「CEO」- -

Mainz Biomed N V Ord Shsの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David Elliot Lazar
Mr. David Elliot Lazar
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
55.06M
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
Non-Executive Independent Director
Non-Executive Independent Director
252.00K
+44.79%
Mr. David Natan
Mr. David Natan
Non-Executive Independent Director
Non-Executive Independent Director
137.14K
--
Mr. Peter O'Rourke
Mr. Peter O'Rourke
Independent Director
Independent Director
137.14K
--
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David Elliot Lazar
Mr. David Elliot Lazar
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
55.06M
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
Non-Executive Independent Director
Non-Executive Independent Director
252.00K
+44.79%
Mr. David Natan
Mr. David Natan
Non-Executive Independent Director
Non-Executive Independent Director
137.14K
--
Mr. Peter O'Rourke
Mr. Peter O'Rourke
Independent Director
Independent Director
137.14K
--
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%

よくある質問

Mainz Biomed N V Ord Shsの䞊䜍5名の株䞻は誰ですか


Mainz Biomed N V Ord Shsの䞊䜍5名の株䞻は以䞋のずおりです。Mr. David Elliot Lazar
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。